Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
704 articles
📰
Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<ul...
📰
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
DEER PARK, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative...
📰
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
SAN JOSE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (NASDAQ:RANI), a...
📰
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call
RICHMOND, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company today announced that the...
📰
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<ul...
📰
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
CORAL GABLES, Fla., March 19, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage...
Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results
SAN DIEGO, March 19, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (NASDAQ:INBX) ("Inhibrx" or the "Company") today reported financial results for...
Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results
SAN DIEGO, March 19, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for...
Curis Provides Fourth Quarter 2025 Business Update
Management to host conference call today at 4:30 p.m. ET
LEXINGTON, Mass., March 19, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology...
Curis Provides Fourth Quarter 2025 Business Update
Management to host conference call today at 4:30 p.m. ET LEXINGTON, Mass., March 19, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology...
📰
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026
NEWTON, Mass., March 19, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) ("Acumen" or the "Company"), a clinical-stage...
📰
Pfizer vs Moderna: Which Pharma Stock Has More Upside?
They aren't just "pandemic stocks."
📰
Pfizer vs Moderna: Which Pharma Stock Has More Upside?
They aren't just "pandemic stocks."
📰
Pfizer vs Moderna: Which Pharma Stock Has More Upside?
They aren't just "pandemic stocks."
Re:Build Cadonix Arcadia y smartBuild, seleccionadas por CNH para mejorar el diseño de haces de cables
-Re:Build Cadonix Arcadia y smartBuild, seleccionadas por CNH para ayudar a mejorar el diseño y la fabricación de haces de cables FRAMINGHAM,...
CNH choisit Arcadia et smartBuild de Re:Build Cadonix pour améliorer la conception et la fabrication des faisceaux de câbles.
FRAMINGHAM, Massachusetts, 19 mars 2026 /PRNewswire/ -- CNH, une société d'équipement, de technologie et de services de classe mondiale, spécialisée...
📰
Aveanna (AVAH) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, March 19, 2026, at 10 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰
ALGN or WST: Which Is the Better Value Stock Right Now?
ALGN vs. WST: Which Stock Is the Better Value Option?
📰
ALGN or WST: Which Is the Better Value Stock Right Now?
ALGN vs. WST: Which Stock Is the Better Value Option?
📰
BTSG or ALHC: Which Is the Better Value Stock Right Now?
BTSG vs. ALHC: Which Stock Is the Better Value Option?
📰
BTSG or ALHC: Which Is the Better Value Stock Right Now?
BTSG vs. ALHC: Which Stock Is the Better Value Option?
📰
DarioHealth (DRIO) Q4 2025 Earnings Transcript
Image source: The Motley Fool.Thursday, March 19, 2026 at 8:30 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰
Best Low-Beta Stocks to Own Right Away: AGRO, PRA, E & LQDA
Low-beta picks gain focus as Iran war fears stir volatility. AGRO, PRA, E and LQDA reflect resilience with momentum, liquidity and fundamentals.
📰
Home Telecom Completes High-Split HFC Modernization with Teleste and Mega Hertz
Deployment of Teleste ICON intelligent amplifiers and Argus NMS strengthens reliability, improves operational visibility, and prepares the network...
📰
Biofrontera (BFRI) Q4 2025 Earnings Transcript
Image source: The Motley Fool.Thursday, March 19, 2026 at 10 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
GEHC & Springbok Collaborate on MRI Muscle Analysis for Sports
GE HealthCare teams with Springbok to pair MRI tech with AI muscle analytics, aiming to redefine how muscle health is measured and visualized.
📰
Are Options Traders Betting on a Big Move in Harmony Biosciences Stock?
Investors need to pay close attention to Harmony Biosciences stock based on the movements in the options market lately.
📰
Taysha (TSHA) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, March 19, 2026 at 8:30 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
SANY und OCHA unterzeichnen Partnerschaftsvereinbarung bei der HNPW 2026
PEKING, 19. März 2026 /PRNewswire/ -- Während der Humanitarian Networks and Partnerships Week (HNPW) 2026 unterzeichneten die SANY Foundation und das...